Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study.

By U. Srinivas-Shankar, S. Roberts, M. Connolly, M. O’Connell, J. Adams, J. Oldham, Frederick C W Wu. Journal of Clinical Endocrinology and Metabolism, 2010

600 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/d19f23038ef8646fa2d1a696317c33c2f0cb1b85

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. S. Bhasin
2. T. Malmstrom
3. G. Cunningham
4. Douglas K. Miller
5. F. Hayes
6. A. Matsumoto
7. Frederick C W Wu
8. J. Brito

Citations in the corpus

• Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. (2018, positive): “In placebo-controlled trials in healthy and mobility-limited older men, T therapy resulted in greater gains in lean body mass (LBM), maximal voluntary strength, muscle power, and some performance-based measures of physical function vs placebo (79 – 83).”
• A SIMPLE FRAILTY QUESTIONNAIRE (FRAIL) PREDICTS OUTCOMES IN MIDDLE AGED AFRICAN AMERICANS (2012, background): “Evidence is emerging that targeted therapies may decrease the negative outcomes associated with being frail (4-6).”